dermatofibrosarcoma protuberans (Cancer)
Information
- Disease name
- dermatofibrosarcoma protuberans
- Disease ID
- DOID:3507
- Description
- "A fibrosarcoma that is located_in the dermis laryer of the skin and that begins as a hard nodule and grows slowly." [url:http\://en.wikipedia.org/wiki/Dermatofibrosarcoma_protuberans, url:http\://www.cancer.gov/dictionary?CdrID=44276]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00084630 | Completed | Phase 2 | Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans | May 2004 | |
| NCT00243191 | Completed | Phase 2 | Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans | May 2006 | September 2009 |
| NCT00346164 | Completed | Phase 3 | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma | February 5, 2007 | March 31, 2022 |
| NCT00659360 | Completed | Phase 2 | AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma | February 2008 | November 2012 |
| NCT00720174 | Completed | Phase 1 | Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma | June 2008 | |
| NCT01154452 | Completed | Phase 1/Phase 2 | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma | June 2010 | February 2015 |
| NCT03381846 | Completed | N/A | Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger | July 1, 2018 | June 30, 2020 |
- Disase is a (Disease Ontology)
- DOID:3355
- Cross Reference ID (Disease Ontology)
- GARD:9569
- Cross Reference ID (Disease Ontology)
- ICDO:8832/1
- Cross Reference ID (Disease Ontology)
- MESH:D018223
- Cross Reference ID (Disease Ontology)
- MIM:607907
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:302844005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0206647
- OrphaNumber from OrphaNet (Orphanet)
- 31112